In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6g and the use of a coated coil as a new drug delivery system

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 6, 2002, Pages 559-569

  Cruysberg, Lars P J ^a,b   Nuijts, Rudy M M A ^b   Geroski, Dayle H ^a   Koole, Leo H ^b   Hendrikse, Fred ^b   Edelhauser, Henry F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DEXAMETHASONE; DYE; FLUORESCEIN; METHOTREXATE; RHODAMINE 6G;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR WEIGHT; PERFUSION; SCLERA; STEADY STATE; SUSTAINED DRUG RELEASE;

EID: 0036912268     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076802321021108     Document Type: Article

References (22)

1. Barza, M. Kane, A. and Baum, J.L. Intraocular penetration of gentamicin after subconjunctival and retrobulbair injection. Am. J. Ophthalmol. 85:541-547, 1978.
2. Maurice, D.M., and Polgar, J. Diffusion across the sclera. Exp. Eye. Res. 25:577-582, 1977.
3. Olsen, T.W., Edelhauser, H.F., Lim, J.I., and Geroski, D.H. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest. Ophthalmol. Vis. Sci. 36:1893-1903, 1995.
4. Geroski, D.H., and Edelhauser, H.F. Drug delivery for posterior segment eye disease. Invest. Ophthalmol. Vis. Sci. 41:961-964, 2000.
5. Lang, J.C. Ocular drug delivery conventional ocular formulations. Adv. Drug Deliv. Rev. 16: 39-43, 1995.
6. Olsen, T.W., Aaberg, S.Y., Geroski, D.H., and Edelhauser, H.F. Human sclera: thickness and surface area. Am. J. Ophthalmol. 125:237-241, 1998.
7. Rudnick, D.E., Noonan, J.S., Geroski, D.H., Prausnitz, M.R., and Edelhauser, H.F. The effect of intraocular pressure on human and rabbit scleral permeability. Invest. Ophthalmol. Vis. Sci. 40:3054-3058, 1999.
8. Schoenwald, R.D., Deshpande, G.S., Rethwisch, D.G., and Barfknecht, C.F. Penetration into the anterior chamber via the conjunctival/scleral pathway. J. Ocul. Pharmacol. 13:41-59, 1997.
9. Hanssen, H.H.L., Wetzels, G.M.R., Benzina, A., Van der Veen, F.H., Lindhout, T., and Koole, L.H. Metallic wires with an adherent lubricious and blood-compatible polymeric coating and their use in the manufacture of a novel slippery-when-wet guidewires: Possible applications related to controlled local drug delivery. J. Biomed. Mater. Res. (Appl Biomater) 48:820-828, 1999.
10. Prausnitz, M.R., and Noonan, J.S. Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye. J. Pharm. Sci. 87:1479-1488, 1998.
11. Ambati, J., Canakis, C.S., Miller, J.W., Gragoudas, E.S., Edwards, A., Weissgold, D.J., Kim, I., Delori, F.C., and Adamis, A.P. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41:1181-1185, 2000.
12. Maurice, D.M., and Mishima, S. Ocular pharmacokinetics. In Pharmacology of the Eye. Sears, ML, ed., Springer-Verlag, New York, 1984, pp. 19-116.
13. Unlu, N., and Robinson, J.R. Scleral permeability to hydrocortisone and mannitol in the albino rabbit eye. J. Ocul. Pharmacol. Ther. 14:273-281, 1998.
14. Tao, L., and Nicholson, C. Diffusion of albumins in rat cortical slices and relevance to volume transmission. Neuroscience 75:839-847, 1996.
15. Edwards, A., and Prausnitz, M.R. Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. Am. Inst. Chem. Eng. J. 44:214-225, 1998.
16. Cooper, E.R., and Kasting, G. Transport across epithelial membranes. J. Control Rel. 6:23-35, 1987.
17. Newell, F.V. Ophthalmology, Principles and Concepts, 6th Ed. CV Mosby Co., St Louis, 1996.
18. Foster, C.S., and Sainz de la Maza, M. The Sclera. Springer-Verlag, New York, 1994, pp. 1-32.
19. Hämäläinen, K.M., Kananen, K., Auriola, S., Kontturi, K., and Urtti, A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest. Ophthalmol. Vis. Sci. 38:627-634, 1997.
20. Hochman, J., and Artursson, P. Mechanisms of absorption enhancement and tight junction regulation. J. Control Rel. 29:253-267, 1994.
21. Ambati, J., Gragoudas, E.S., Miller, J.W., You, T.T., Miyamoto, K., Delori, F.C., and Adamis, A.P. Transscleral delivery of bioactive protein to the choroid and retina. Invest. Ophthalmol. Vis. Sci. 41:1186-1191, 2000.
22. Weijtens, O., Schoemaker, R.C., Lentjes, E.G., Romijn, F.P., Cohen, A.F., and Van Meurs, J.C. Dexamethasone concentration in the subretinal fluid after subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology 107:1932-1938, 2000.